Eli Lilly's muvalaplin Phase 2 trial showed significant Lp(a) reduction, meeting primary and secondary endpoints with ...

Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

Managing diabetes and high cholesterol often requires lifestyle changes, such as eating healthier, exercising, and sometimes ...

Eating plant-based foods that are rich in fiber and healthy fats through what’s long been known as the portfolio diet is one ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Statins are widely used medications to lower high cholesterol, and many people rely on rosuvastatin, a popular drug in this ...

Dr. Eugene Braunwald is often called the father of modern cardiology. He calls that an exaggeration. "Maybe I've been around ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Unexplained fluctuations in cholesterol levels have been linked to dementia and cognitive decline in a recent study.